SCHEMBL6583607

SCHEMBL6583607

O=C1OC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 4/20 0.58
SIRT2 Q8IXJ6 3/20 0.58
PRKCA P17252 2/20 0.58
CAMK2D Q13557 2/20 0.58
PRKD3 O94806 1/20 0.58
CCNB2 O95067 1/20 0.58
CCNE2 O96020 1/20 0.58
ABL1 P00519 1/20 0.58
PRKCG P05129 1/20 0.58
CDK1 P06493 1/20 0.58
PIM1 P11309 1/20 0.58
CDK4 P11802 1/20 0.58
CCNB1 P14635 1/20 0.58
PRKACA P17612 1/20 0.58
PRKACG P22612 1/20 0.58
PRKACB P22694 1/20 0.58
CCND1 P24385 1/20 0.58
PRKCH P24723 1/20 0.58
CCNE1 P24864 1/20 0.58
CDK2 P24941 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197287 0.92 PRKCB (0.68) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL3148490 0.81 PRKCB (0.84) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL8316185 0.77 PRKCB (0.50) PRKCBSIRT2PRKCACAMK2DPRKD3
3-Phenylindole SCHEMBL29609072 0.77 IMPDH2 (0.71) PRKCBSIRT2PRKCACAMK2DPRKD3
3-Phenylindole SCHEMBL84056 0.77 IMPDH2 (0.71) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL7831969 0.76 PRKACA (0.77) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL7827326 0.76 PDGFRB (0.50) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL7814853 0.76 KDR (0.58) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL24115421 0.74 PRKCB (0.58) PRKCBSIRT2PRKCACAMK2DPRKD3
SCHEMBL592300 0.74 PTGS2 (0.65) MAPTNPSR1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307447-B1 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA HOFFMANN LA ROCHE (CH) 2004-12-15 EP claimed
EP-1307447-A2 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA F. HOFFMANN-LA ROCHE AG (CH) 2003-05-07 EP claimed
US-20020188018-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GONG LEYI (US) 2002-12-12 US claimed
US-6479490-B2 TREATMENT OF DISEASES CHARACTERIZED BY EXCESS TH2 CYTOKINES AND/ OR AN EXCESS IGE PRODUCTION. SYNTEX (U.S.A.) LLC 2002-11-12 US claimed
US-20020052397-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta SYNTEX (U.S.A.) LLC 2002-05-02 US claimed
WO-2002010158-A2 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA F. HOFFMANN-LA ROCHE AG (CH) 2002-02-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052397-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GSK3B, GSK3A, PYGL PRKCB 62/4885SIRT2 1915/4885PRKCA 61/4885
US-20020188018-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GSK3B, GSK3A, PYGL PRKCB 51/4885SIRT2 2688/4885PRKCA 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.